Comerica Bank’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Comerica Bank’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,226	Closed	-$412K	–	2086
2014 Q4	$412K	Buy	+12,226	New	+$432K	﹤0.01%	1980
2014 Q3	–	Sell	-43,327	Closed	-$1.42M	–	2135
2014 Q2	$1.42M	Sell	43,327 -5,250	-11%	-$180K	0.01%	1300
2014 Q1	$1.79M	Buy	48,577 +25,038	+106%	+$919K	0.01%	1211
2013 Q4	$903K	Buy	+23,539	New	+$743K	0.01%	1608

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Comerica Bank's WX Position: Q1 2015 in Review

Comerica Bank sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 12,226 shares — an estimated $412K sold.

Comerica Bank first reported a position in WX in Q4 2013 and held it in 4 quarters. The position peaked at $1.79M in Q1 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Comerica Bank reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Comerica Bank sold 12,226 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $412K.
Comerica Bank first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 4 quarters.
Comerica Bank's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.79M in Q1 2014.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Comerica Bank's 13F filing for Q1 2015, filed 15 May 2015.